Xcout Intel
Nusano, Inc.
Nusano, Inc. is a U.S. isotope-production company that uses particle-accelerator technology to manufacture radioisotopes. It serves pharmaceutical, medical, industrial, and research customers, with operations associated with a large production facility in West Valley City, Utah.
Subscribe to see Nusano, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nusano, Inc. at a glance
Nusano, Inc. is a medical devices company headquartered in United States. It has raised at least $173M across the 3 funding rounds on record. Its most recent funding round, Series C, raised $115M in October 2024. Xcout tracks 1 named person at Nusano, Inc., including Chris Lowe (CEO). Xcout recorded 17 job postings from Nusano, Inc. in the last 90 days, naming tools such as Epicor.
Nusano, Inc. leadership
- Chris LoweCEO
Nusano, Inc. funding rounds
At least $173M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $115M | 2 named | |
| SEC Form D filing | $10M | — | |
| SEC Form D filing | $48M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Nusano, Inc.
Xcout recorded 17 job postings from Nusano, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in Nusano, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Nusano, Inc.'s hiring signals →
Investors
Tech stack
Nusano, Inc. competitors
A few of Nusano, Inc.'s closest competitors — see the full list of competitors and alternatives →
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Ultrasonium is an advanced metals manufacturing company that produces complex metal parts for critical engineering systems. The company utilizes a founding team with expertise in sectors like aerospace, nuclear reactors, and quantum computing to manufacture parts significantly faster and more cost-effectively than traditional methods.
Get Nusano, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nusano, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access